Blocker Nucleic Acid RNA Detection for Non-Specific PCR Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing RNA detection methods suffer from non-specific reactions, leading to false positives and reduced sensitivity and accuracy, particularly in the detection of small RNAs such as miRNAs, which are crucial for early disease diagnosis.
Innovation Solution
A method involving the use of a blocker nucleic acid that complements and binds to sensor DNA that has not hybridized with target RNA, inhibiting non-specific amplification during PCR, thereby enhancing the specificity and sensitivity of RNA detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional RNA detection methods are used, then the detection process is simple, but non-specific reactions occur leading to false positives and reduced sensitivity and accuracy
Solution Approach 1:
A blocker nucleic acid is introduced as an intermediary substance that specifically binds to unhybridized sensor DNA, preventing it from participating in non-specific amplification reactions. This mediator selectively eliminates false positive signals while preserving the specific target detection capability, thereby improving detection accuracy without requiring fundamental changes to the overall detection methodology
Solution Approach 2:
The blocker nucleic acid performs preliminary inhibition of non-specific reactions by binding to and neutralizing unhybridized sensor DNA before these molecules can participate in spurious amplification. This pre-emptive action prevents false positives from occurring in the first place, enhancing the reliability of the detection results
2Measurement precision
If detection sensitivity is increased to detect small RNAs, then early disease diagnosis capability improves, but non-specific reactions increase leading to false positives
Solution Approach 1:
The blocker nucleic acid serves as a selective intermediary that distinguishes between specific and non-specific binding events. It binds only to unhybridized sensor DNA, allowing the system to maintain high sensitivity for detecting small RNA targets while simultaneously filtering out non-specific signals that would otherwise cause false positives
Solution Approach 2:
The blocker nucleic acid introduces local specificity into the detection system by targeting only the unhybridized portion of the sensor DNA. This localized action affects only the problematic non-specific signals while leaving the specific target detection pathway untouched, thereby improving accuracy without sacrificing sensitivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high sensitivity and accuracy in RNA detection, with a detection limit at femtomole and attomole levels, effectively eliminating non-specific reactions and improving the reliability of RNA detection, especially for small RNAs like miRNAs.
Implementation Method 1
a) hybridizing a sensor DNA, which includes a sequence complementary to a target RNA to be detected, with the target RNA
Implementation Method 2
b) performing polymerization using a polymerase, in which a module region of the sensor DNA is used as a template and the target RNA is used as a primer
Implementation Method 3
c) treating the blocker nucleic acid that complementarily binds to the sensor DNA thereto to inhibit amplification of the sensor DNA that does not hybridize with target RNA
Data Source
AI summary
The present invention relates to a method for detecting a target RNA, which includes treating a blocker nucleic acid. In particular, the method of the present invention can inhibit non-specific reactions through the treatment of the blocker nucleic acid, and analyze even short RNA sequences, thereby enabling detection with high sensitivity and accuracy, and thus can be widely utilized for the diagnosis of various diseases such as infections and cancers.